European Pharmaceutical Review
AUGUST 15, 2023
The Milan region is at the centre of Italy’s pharmaceutical base, with over 50 facilities in the Lombardy region alone. The annual CPHI event is the most comprehensive reference point for the global pharmaceutical industry and is the ideal platform to build networks, meet existing partners, and learn about the latest trends.
Contrarian Sales Techniques
FEBRUARY 29, 2024
Prepare for interviews: Research common interview questions for pharmaceutical sales and practice your answers beforehand. Network and build connections Attend industry events: Participate in conferences, workshops, or career fairs related to the pharmaceutical industry to establish connections and gain insights.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
JULY 21, 2023
Some relevant groups to join include: Pharmaceutical Research and Manufacturers of America (PhRMA), Biotechnology Innovation Organization (BIO), and American Society of Clinical Oncology (ASCO). Attending events is a great way to make new connections and to position yourself as a thought leader in your field.
Pharma Marketing Network
JANUARY 26, 2022
Throughout her decades-long career, Seidenberg has transformed the lives of millions of patients by championing pharmaceutical research and development leading to the introduction of innovative life-saving products that treat diseases like AIDS, arthritis, asthma, cancer, and others.
PharmaKinnex
AUGUST 23, 2022
Bearing the brunt of these COVID19 restrictions, pharmaceutical reps have had a hard time getting in the door to make sales, and their employers have noticed: Limited In-Person Access To HCPs. Fewer Networking & Industry Trade Show Events. Higher Travel & Marketing Costs. Increased Product & Legal Knowledge Requirements.
Pharma Marketing Network
MAY 3, 2023
This involves paying researchers and scientists to publish articles or conduct studies that support the use of a particular drug, while suppressing or ignoring research that casts doubt on the drug’s safety or efficacy. Pharmaceutical research and development: what do we get for all that money? References: 1.
European Pharmaceutical Review
SEPTEMBER 22, 2023
Targeting toxic species of Abeta, such as multimers (with aducanumab and lecanemab) or pyroglutamate Abeta3-42 (with donanemab), induced significant removal of Abeta plaque load in the brains of Alzheimer’s patients, leading to the delay in cognitive decline. Treatment with the mAbs delayed cognitive decline by 2.6 months for lecanemab and 5.5
Expert insights. Personalized for you.
89 
Let's personalize your content